Literature DB >> 10608380

Pelvic discontinuity in revision total hip arthroplasty.

D J Berry1, D G Lewallen, A D Hanssen, M E Cabanela.   

Abstract

BACKGROUND: Pelvic discontinuity is a distinct form of bone loss, occurring in association with total hip arthroplasty, in which the superior aspect of the pelvis is separated from the inferior aspect because of bone loss or a fracture through the acetabulum. The purpose of this study was to describe the population of patients who are at risk for this condition, to identify the characteristic radiographic features associated with it, and to report the results of revision total hip arthroplasty for the treatment of pelvic discontinuity.
METHODS: The cases of all twenty-seven patients (thirty-one hips) who were identified as having a pelvic discontinuity at the time of a reoperation for a failed hip arthroplasty at one institution were reviewed retrospectively, and demographic information was collected. The preoperative radiographs and the operative notes were reviewed, and the postoperative results and complications were recorded.
RESULTS: Pelvic discontinuity was identified in association with thirty-one (0.9 percent) of 3505 acetabular revisions. The mean age of the patients was sixty-one years (range, thirty-eight to eighty years). Twenty-eight hips were in women, and three were in men. Women (p < 0.001) and patients who had rheumatoid arthritis (p = 0.003) had a significantly increased risk of pelvic discontinuity. The radiographic findings included a visible fracture line through the anterior and posterior columns, medial translation of the inferior aspect of the hemipelvis relative to the superior aspect (seen as a break in Kohler's line), and rotation of the inferior aspect of the hemipelvis relative to the superior aspect (seen as asymmetry of the obturator rings) on a true anteroposterior radiograph. Two patients died within two years after the revision, and two had a resection arthroplasty for the treatment of the pelvic discontinuity; thus, twenty-seven hips were reconstructed and were eligible for follow-up at least two years after the operation. A number of different methods were used for reconstruction, but the results were best in patients who did not have severe segmental acetabular bone loss (type IVa [a satisfactory result in three of three hips]) and poorer in those who had severe segmental or combined segmental and cavitary bone loss (type IVb [a satisfactory result in ten of nineteen hips]) and in those who previously had been treated with irradiation to the pelvis (type IVc [a satisfactory result in three of five hips]). Nine of the twenty-seven hips needed another operation: four, because of aseptic loosening of the acetabular component; four, because of recurrent dislocation; and one, because of deep infection. Excluding three hips that were revised early because of infection or dislocation, a mechanically stable construct (that is, a stable socket and a possibly or definitely healed discontinuity) was obtained in seventeen of twenty-four hips.
CONCLUSIONS: Pelvic discontinuity is uncommon, and treatment is associated with a high rate of complications. For hips with type-IVa bone loss and selected hips with type-IVb defects, in which a socket inserted without cement can be satisfactorily supported by native bone, we prefer to use a posterior column plate to stabilize the pelvis and a porous-coated socket inserted without cement. For most hips with type-IVb and type-IVc bone loss, we prefer to use particulate bone graft or a single structural bone graft protected with an antiprotrusion cage.

Entities:  

Mesh:

Year:  1999        PMID: 10608380     DOI: 10.2106/00004623-199912000-00006

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  44 in total

1.  Pelvic discontinuity treated with custom triflange component: a reliable option.

Authors:  Michael J Taunton; Thomas K Fehring; Paul Edwards; Thomas Bernasek; Ginger E Holt; Michael J Christie
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

2.  The survival and fate of acetabular reconstruction with impaction grafting for large defects.

Authors:  Eduardo Garcia-Cimbrelo; Ana Cruz-Pardos; Eduardo Garcia-Rey; José Ortega-Chamarro
Journal:  Clin Orthop Relat Res       Date:  2010-12       Impact factor: 4.176

3.  CORR Insights(®): Custom Acetabular Cages Offer Stable Fixation and Improved Hip Scores for Revision THA With Severe Bone Defects.

Authors:  Thomas Jefferson Blumenfeld
Journal:  Clin Orthop Relat Res       Date:  2015-12-16       Impact factor: 4.176

4.  Section of the sciatic nerve by a metal acetabulum reinforcement ring: a literature review through one case.

Authors:  S Ruatti; M Grimaldi; D Saragaglia
Journal:  Eur J Orthop Surg Traumatol       Date:  2011-10-04

5.  [Treatment of acetabular defects with the trabecular metal revision system].

Authors:  G I Wassilew; V Janz; C Perka; M Müller
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

Review 6.  Treatment algorithm of acetabular periprosthetic fractures.

Authors:  Paul Simon; Philipp von Roth; Carsten Perka
Journal:  Int Orthop       Date:  2015-08-30       Impact factor: 3.075

7.  Acetabular cage survival and analysis of factors related to failure.

Authors:  Jonathan N Sembrano; Edward Y Cheng
Journal:  Clin Orthop Relat Res       Date:  2008-02-26       Impact factor: 4.176

8.  Complications of total hip arthroplasty: periprosthetic fractures of the acetabulum.

Authors:  Amol Chitre; Henry Wynn Jones; Nikhil Shah; Anthony Clayson
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

9.  [Acetabular revision surgery with the oblong revision cup : clinical and radiological results of 217 cases].

Authors:  S Fickert; S Pfeiffer; A Walter; K P Günther; W-C Witzleb
Journal:  Orthopade       Date:  2010-05       Impact factor: 1.087

10.  Can the volume of pelvic osteolysis be calculated without using computed tomography?

Authors:  Hiroshi Egawa; Cara C Powers; Sarah E Beykirch; Robert H Hopper; C Anderson Engh; Charles A Engh
Journal:  Clin Orthop Relat Res       Date:  2008-09-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.